Kory James Wentworth
Chief Financial Officer · 5 filings · Latest: Sep 2, 2026
Entrada Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TRDA | Kory James Wentworth | Chief Financial Officer | Apr 1, 2026 | Sale | $12.95 | 2,500 | $32.4K | 119,010 | |
TRDA | KORY WENTWORTH | — | Apr 1, 2026 | Proposed Sale | $12.62 | 2,500 | $31.6K | — | |
TRDA | Kory James Wentworth | Chief Financial Officer | Mar 10, 2026 | Sale | $13.02 | 11,388 | $148.2K | 121,510 | |
TRDA | Kory James Wentworth | Chief Financial Officer | Mar 9, 2026 | Sale | $13.00 | 5,089 | $66.2K | 132,898 | |
TRDA | KORY WENTWORTH | — | Mar 9, 2026 | Proposed Sale | $12.58 | 16,477 | $207.3K | — | |
TRDA | Kory James Wentworth | Chief Financial Officer | Mar 4, 2026 | Sale | $12.25 | 7,988 | $97.9K | 137,987 | |
TRDA | KORY WENTWORTH | — | Mar 4, 2026 | Proposed Sale | $11.85 | 7,988 | $94.7K | — | |
TRDA | KORY WENTWORTH | — | Nov 21, 2025 | Proposed Sale | $9.17 | 8,910 | $81.7K | — | |
TRDA | KORY WENTWORTH | — | Mar 17, 2025 | Proposed Sale | $10.81 | 1,784 | $19.3K | — | |
TRDA | KORY WENTWORTH | — | Nov 11, 2024 | Proposed Sale | $19.82 | 14,637 | $290.1K | — | |
TRDA | KORY WENTWORTH | — | Sep 9, 2024 | Proposed Sale | $14.80 | 3,195 | $47.3K | — |